U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H13Cl2N3.BrH
Molecular Weight 351.07
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALINIDINE HYDROBROMIDE

SMILES

Br.ClC1=CC=CC(Cl)=C1N(CC=C)C2=NCCN2

InChI

InChIKey=JLFOQBZGELKSOT-UHFFFAOYSA-N
InChI=1S/C12H13Cl2N3.BrH/c1-2-8-17(12-15-6-7-16-12)11-9(13)4-3-5-10(11)14;/h2-5H,1,6-8H2,(H,15,16);1H

HIDE SMILES / InChI

Molecular Formula C12H13Cl2N3
Molecular Weight 270.158
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Alinidine, a specific bradycardiac agent, which reduces myocardial oxygen consumption and improves exercise tolerance in patients with angina pectoris. In randomized controlled trial alinidine did not enhance myocardial salvage or preservation of left ventricular function of major arrhythmias in the early phase of infarction. The development of this drug was stopped because it was not sufficiently specific for its target.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pharmacological stimulation and inhibition of insulin secretion in mouse islets lacking ATP-sensitive K+ channels.
2010-02-01
Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
2009-12
Heart rate and cardiovascular disease: an alternative to Beta blockers.
2009
Antagonism of the insulinotropic action of first generation imidazolines by openers of K(ATP) channels.
2007-01-01
Molecular regulation and pharmacology of pacemaker channels.
2007
[Selective I(f) channel inhibition: an alternative for treating coronary artery disease?].
2006-02
Physiology and pharmacology of the cardiac pacemaker ("funny") current.
2005-07
Reduction of heart rate by chronic beta1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart.
2005-06
Angiogenesis in ischaemic and hypertrophic hearts induced by long-term bradycardia.
2005
Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart.
2004-08-17
Specificity of nonadrenergic imidazoline binding sites in insulin-secreting cells and relation to the block of ATP-sensitive K(+) channels.
2003-12
Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?
2003-06
Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
2001-12-15
Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies.
2001-12-15
Control of catecholamine-induced tachycardia with alinidine in the anesthetized dog.
1987-08
Alinidine in angina.
1983-12
Effect of alinidine on experimental cardiac arrhythmias.
1982-03-01
Patents

Sample Use Guides

alinidine (20 to 40 mg intravenously followed by 20 to 40 mg orally every 8 h)
Route of Administration: Other
Substance Class Chemical
Created
by admin
on Mon Mar 31 23:00:29 GMT 2025
Edited
by admin
on Mon Mar 31 23:00:29 GMT 2025
Record UNII
Q8XXC72UBI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ST 567-BR
Preferred Name English
ALINIDINE HYDROBROMIDE
Common Name English
1H-IMIDAZOL-2-AMINE, N-(2,6-DICHLOROPHENYL)-4,5-DIHYDRO-N-2-PROPENYL-, MONOHYDROBROMIDE
Systematic Name English
ST-567-BR
Code English
1H-IMIDAZOL-2-AMINE, N-(2,6-DICHLOROPHENYL)-4,5-DIHYDRO-N-2-PROPEN-1-YL-, HYDROBROMIDE (1:1)
Systematic Name English
STH-567BR
Code English
1H-IMIDAZOL-2-AMINE, 4,5-DIHYDRO-N-(2,6-DICHLOROPHENYL)-N-2-PROPENYL-, MONOHYDROBROMIDE
Common Name English
Code System Code Type Description
FDA UNII
Q8XXC72UBI
Created by admin on Mon Mar 31 23:00:29 GMT 2025 , Edited by admin on Mon Mar 31 23:00:29 GMT 2025
PRIMARY
CAS
71306-36-0
Created by admin on Mon Mar 31 23:00:29 GMT 2025 , Edited by admin on Mon Mar 31 23:00:29 GMT 2025
PRIMARY
PUBCHEM
134052
Created by admin on Mon Mar 31 23:00:29 GMT 2025 , Edited by admin on Mon Mar 31 23:00:29 GMT 2025
PRIMARY
EPA CompTox
DTXSID10221461
Created by admin on Mon Mar 31 23:00:29 GMT 2025 , Edited by admin on Mon Mar 31 23:00:29 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY